These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 29368418)

  • 1. Ileocolonic neuroendocrine tumours identified in the English bowel cancer screening programme.
    Basuroy R; O'Donnell CM; Srirajaskanthan R; Ramage JK
    Colorectal Dis; 2018 Apr; 20(4):O85-O91. PubMed ID: 29368418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decade.
    Kooyker AI; Verbeek WH; van den Berg JG; Tesselaar ME; van Leerdam ME
    United European Gastroenterol J; 2020 Feb; 8(1):59-67. PubMed ID: 32213058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of the faecal immunochemical test at a range of positivity thresholds compared with the guaiac faecal occult blood test in the NHS Bowel Cancer Screening Programme in England.
    Murphy J; Halloran S; Gray A
    BMJ Open; 2017 Oct; 7(10):e017186. PubMed ID: 29079605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme.
    Lee TJ; Rutter MD; Blanks RG; Moss SM; Goddard AF; Chilton A; Nickerson C; McNally RJ; Patnick J; Rees CJ
    Gut; 2012 Jul; 61(7):1050-7. PubMed ID: 21940723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-neoplastic findings at colonoscopy after positive faecal occult blood testing: data from the English Bowel Cancer Screening Programme.
    Bevan R; Lee TJ; Nickerson C; Rubin G; Rees CJ;
    J Med Screen; 2014 Jun; 21(2):89-94. PubMed ID: 24644029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme.
    Lee TJ; Clifford GM; Rajasekhar P; Rutter MD; Kometa S; Ritchie MC; Waddup G; Nylander D; McNally RJ; Rees CJ
    J Med Screen; 2011; 18(2):82-6. PubMed ID: 21852700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experience with a two-tier reflex gFOBT/FIT strategy in a national bowel screening programme.
    Fraser CG; Digby J; McDonald PJ; Strachan JA; Carey FA; Steele RJ
    J Med Screen; 2012 Mar; 19(1):8-13. PubMed ID: 22156144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress.
    Modlin IM; Champaneria MC; Chan AK; Kidd M
    Am J Gastroenterol; 2007 Jul; 102(7):1464-73. PubMed ID: 17391319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results from a pilot study within the national screening programme in England.
    Moss S; Mathews C; Day TJ; Smith S; Seaman HE; Snowball J; Halloran SP
    Gut; 2017 Sep; 66(9):1631-1644. PubMed ID: 27267903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Slipping through the bowel cancer screening programme.
    Hallifax R; Lacey M; Bevis P; Borley NR; Brooklyn T; Wheeler JM
    Colorectal Dis; 2012 Jul; 14(7):844-7. PubMed ID: 21920009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocuff-assisted vs. standard colonoscopy in the fecal occult blood test-based UK Bowel Cancer Screening Programme (E-cap study): a randomized trial.
    Bhattacharyya R; Chedgy F; Kandiah K; Fogg C; Higgins B; Haysom-Newport B; Gadeke L; Thursby-Pelham F; Ellis R; Goggin P; Longcroft-Wheaton G; Bhandari P
    Endoscopy; 2017 Nov; 49(11):1043-1050. PubMed ID: 28614895
    [No Abstract]   [Full Text] [Related]  

  • 13. Flexible sigmoidoscopy following a positive faecal occult blood test within a bowel screening programme may reduce the detection of neoplasia.
    Mansouri D; McMillan DC; Roxburgh CS; Moug SJ; Crighton EM; Horgan PG
    Colorectal Dis; 2013 Nov; 15(11):1375-81. PubMed ID: 23927751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme.
    Morris EJ; Whitehouse LE; Farrell T; Nickerson C; Thomas JD; Quirke P; Rutter MD; Rees C; Finan PJ; Wilkinson JR; Patnick J
    Br J Cancer; 2012 Aug; 107(5):757-64. PubMed ID: 22850549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme.
    Morris S; Baio G; Kendall E; von Wagner C; Wardle J; Atkin W; Halloran SP; Handley G; Logan RF; Obichere A; Rainbow S; Smith S; Snowball J; Raine R
    Br J Cancer; 2012 Aug; 107(5):765-71. PubMed ID: 22864455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm.
    Kearns B; Whyte S; Seaman HE; Snowball J; Halloran SP; Butler P; Patnick J; Nickerson C; Chilcott J
    Br J Cancer; 2016 Feb; 114(3):327-33. PubMed ID: 26766733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test.
    Denis B; Ruetsch M; Strentz P; Vogel JY; Guth F; Boyaval JM; Pagnon X; Ebelin JF; Gendre I; Perrin P
    Gut; 2007 Nov; 56(11):1579-84. PubMed ID: 17616542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of colonic neoplasia detection rates in patients screened inside and outside the National Bowel Cancer Screening Program.
    Whitcher S; Magnusson M; Gani J; Oldmeadow C; Pockney PG
    Med J Aust; 2020 Apr; 212(6):275-276. PubMed ID: 32058586
    [No Abstract]   [Full Text] [Related]  

  • 19. The first 3 years of national bowel cancer screening at a single UK tertiary centre.
    Gupta S; Saunders BP; Fraser C; Kennedy RH; Ignjatovic A; Sala S; Marshall S; Suzuki N; Vance M; Thomas-Gibson S
    Colorectal Dis; 2012 Feb; 14(2):166-73. PubMed ID: 21689280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy.
    Brenner H; Tao S
    Eur J Cancer; 2013 Sep; 49(14):3049-54. PubMed ID: 23706981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.